title: [Hormonal contraception for adolescents].
abstract: The new hormonal contraceptives are safe, effective and with fewer side effects than the older formulations. Their incidence of serious complications is low, particularly as compared to the health risk related to pregnancy. Adolescents must be screened for contra-indications before giving them a hormonal contraceptive. Because pills do not prevent sexually transmitted diseases, teenagers should be counselled to use a barrier methods together with COCs. Young girls need frequent follow-up and close monitoring to minimise side effects and to increase compliance and continuation in use. Long-term contraception by implants represents a valid alternative option with an increasing popularity among adolescents.
authors.affiliation: Abteilung für gynäkologische Endokrinologie, Reproduktionsmedizin, Universitätsfrauenklinik, Bern.
authors.forename: M
authors.initials: M
authors.lastname: Butarelli
authors.forename: D
authors.initials: D
authors.lastname: Wunder
authors.forename: C
authors.initials: C
authors.lastname: Bodmer
authors.forename: M
authors.initials: M
authors.lastname: Birkhäuser
mesh_terms: D000293:Adolescent; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects / Q000627:therapeutic use*; D000075202:Contraindications; D003376:Counseling; D003692:Delayed-Action Preparations; D004343:Drug Implants; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D011247:Pregnancy; D011253:Pregnancy in Adolescence / Q000517:prevention & control*; D045167:Progesterone Congeners / Q000008:administration & dosage / Q000627:therapeutic use*; D012749:Sexually Transmitted Diseases / Q000517:prevention & control
chemical_list: D003277:Contraceptives, Oral, Combined; D003692:Delayed-Action Preparations; D004343:Drug Implants; D045167:Progesterone Congeners; D017258:Medroxyprogesterone Acetate